- Research works
- 111 ▲ 288% vs 2013–17
- Citations
- 2k 18.0 per fractional work
- Top-10% rate
- 16.9% record average 16.5%
- Open access
- 47% world 28%
Not ranked overall: Fulcrum Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.1×. Every wedge is a field page.
- Immunology and Microbiology 8.1×
- Biochemistry, Genetics and Molecular Biology 6.0×
- Medicine 2.5×
- Neuroscience 1.8×
- Economics, Econometrics and Finance 0.8×
- Chemistry 0.6×
- Nursing 0.5×
- Psychology 0.4×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Materials Science 0.1×
- Engineering 0.1×
- Mathematics 0.1×
- Computer Science 0.1×
- Earth and Planetary Sciences 0.0×
- Health Professions 0.0×
Who are the top researchers at Fulcrum Therapeutics (United States)?
Ranked on the composite score, Michael W. Dunne lead among researchers whose main affiliation is Fulcrum Therapeutics (United States).
- 1 Michael W. Dunne United States · #410,064 worldwide 20 citations · 28 works
Which keywords describe research at Fulcrum Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Epidemiology and Stem Cells.
- Immune Modulation
- Ubiquitin
- Therapeutic Antibodies
- Antibody Engineering
- Histone Modification
- PD-1 and PD-L1
- Clinical Trials
- Attention-Deficit/Hyperactivity Disorder
- Antibiotic Resistance
- Sickle-cell Disease
- Innate Immunity
- Genetics
- Treatment Guidelines
- Cancer Therapy
- Meta-Analysis
- Stem Cells
- Muscle Regeneration
- CAR T Cells
- Tumor Regression
- Immunotherapy
- Epidemiology
- Cancer Immunotherapy
- Lymphoma
- Chimeric Antigen Receptor
- Skeletal Muscle Atrophy
- Antimicrobial Resistance
- Tumor Microenvironment
- Treatment
- Catheter-Associated Infections
- Urinary Tract Infections
- Pulmonary Hypertension
- Thalassemia
- ADHD
- Glycosylation
- Immune Checkpoint Blockade
- DNA Methylation
- Monoclonal Antibodies
- Fc Receptors
- Proteasome
- Cell-Free DNA
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology6▲ 3.0×15 topics
- Immunotherapy6▲ 16×7 topics
- Cancer Immunotherapy5▲ 69×3 topics
- Tumor Regression5▲ 92×2 topics
- Lymphoma5▲ 58×3 topics
- CAR T Cells4▲ 119×1 topic
- Chimeric Antigen Receptor4▲ 119×1 topic
- Muscle Regeneration3▲ 256×1 topic
- Skeletal Muscle Atrophy3▲ 256×1 topic
- Stem Cells3▲ 27×2 topics
- Antimicrobial Resistance3▲ 28×2 topics
- Meta-Analysis2▲ 7.4×3 topics
- Tumor Microenvironment2▲ 9.9×4 topics
- Cancer Therapy2▲ 7.3×5 topics
- Treatment2▲ 3.3×6 topics
- Treatment Guidelines2▲ 18×3 topics
- Catheter-Associated Infections2▲ 111×1 topic
- Genetics2▲ 5.2×4 topics
- Urinary Tract Infections2▲ 88×1 topic
- Innate Immunity2▲ 10×3 topics
- Pulmonary Hypertension2▲ 25×3 topics
- Sickle-cell Disease2▲ 78×1 topic
- Thalassemia2▲ 78×1 topic
- Antibiotic Resistance2▲ 8.2×3 topics
- ADHD2▲ 81×1 topic
- Attention-Deficit/Hyperactivity Disorder2▲ 81×1 topic
- Glycosylation2▲ 27×3 topics
- Clinical Trials1▲ 4.3×8 topics
- Immune Checkpoint Blockade1▲ 26×1 topic
- PD-1 and PD-L11▲ 26×1 topic
- DNA Methylation1▲ 23×1 topic
- Histone Modification1▲ 37×1 topic
- Monoclonal Antibodies1▲ 29×3 topics
- Antibody Engineering1▲ 42×1 topic
- Fc Receptors1▲ 42×1 topic
- Therapeutic Antibodies1▲ 35×2 topics
- Proteasome1▲ 61×1 topic
- Ubiquitin1▲ 61×1 topic
- Cell-Free DNA1▲ 20×2 topics
- Immune Modulation1▲ 19×2 topics
Which research topics does Fulcrum Therapeutics (United States) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Muscle Physiology and Disorders, Urinary Tract Infections Management and Hemoglobinopathies and Related Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 4 works
- 2 Muscle Physiology and Disorders Molecular Biology 3 works
- 3 Urinary Tract Infections Management Epidemiology 2 works
- 4 Hemoglobinopathies and Related Disorders Genetics 2 works
- 5 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 2 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 7 Epigenetics and DNA Methylation Molecular Biology 1 works
- 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 9 Ubiquitin and proteasome pathways Molecular Biology 1 works
- 10 Antibiotics Pharmacokinetics and Efficacy Pharmacology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Fulcrum Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 288% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.